World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
59
Citations
16715
World Ranking
3389
National Ranking
87

Jan Storek publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jan Storek sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 291 publications — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Jan Storek D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jan Storek sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 59 D-Index — 32nd percentile

32% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Jan Storek is affiliated with the University of Calgary in Canada and has contributed extensively to medical research, focusing primarily on hematology and related fields. Their scholarly output includes research spanning hematopoietic stem cell transplantation, oncology, immunology, pathology, forensic medicine, and neurology.

The scientist has authored numerous papers published in notable venues, including multiple contributions to Blood, Transplantation and Cellular Therapy, Bone Marrow Transplantation, Cytotherapy, and the Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Key recent papers authored or co-authored by Jan Storek include:

  • Impaired natural killer cell counts and cytolytic activity in patients with severe COVID-19 (2020, Blood Advances)
  • Composite GRFS and CRFS Outcomes After Adult Alternative Donor HCT (2020, Journal of Clinical Oncology)
  • Genomic instability in early systemic sclerosis (2022, Journal of Autoimmunity)
  • A pilot trial of autologous hematopoietic stem cell transplant in neuromyelitis optic spectrum disorder (2021, Multiple Sclerosis and Related Disorders)
  • Risk Factors for the Incidence of and the Mortality due to Post-Transplant Lymphoproliferative Disorder after Hematopoietic Cell Transplantation (2021, Transplantation and Cellular Therapy)

Frequent co-authors collaborating with Jan Storek include Kareem Jamani, Faisal Khan, Poonam Dharmani-Khan, Rutvij A. Khanolkar, and Amit Kalra. These collaborations highlight a consistent network of researchers contributing to the advancement of knowledge in overlapping scientific domains.

The main fields and subfields of study for Jan Storek's research are:

  • Medicine
  • Hematology
  • Oncology
  • Immunology
  • Pathology and Forensic Medicine
  • Neurology

Research topics frequently addressed in their publications include:

  • Hematopoietic Stem Cell Transplantation
  • Acute Myeloid Leukemia Research
  • Systemic Sclerosis and Related Diseases
  • Viral-associated cancers and disorders
  • Immune Cell Function and Interaction
  • Acute Lymphoblastic Leukemia research
  • Polyomavirus and related diseases

Best Publications

  • Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.

    Marcie Tomblyn;Tom Chiller;Hermann Einsele;Ronald Gress

  • Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective

    M. Tomblyn;T. Chiller;H. Einsele;R. Gress

  • Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia

    Christopher N. Hahn;Christopher N. Hahn;Chan-Eng Chong;Chan-Eng Chong;Catherine L. Carmichael;Ella J. Wilkins;Ella J. Wilkins

  • Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.

    K. M. Sullivan;E. A. Goldmuntz;L. Keyes-Elstein;P. A. McSweeney

  • Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation.

    Jan Storek;Monja A. Dawson;Barry Storer;Terry Stevens-Ayers

  • Allogeneic Peripheral Blood Stem Cell Transplantation May Be Associated With a High Risk of Chronic Graft-Versus-Host Disease

    Jan Storek;Ted Gooley;Muriel Siadak;William I. Bensinger

  • Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study

    Richard K Burt;Yvonne Loh;Bruce Cohen;Dusan Stefosky

  • Vaccination of hematopoietic cell transplant recipients.

    P Ljungman;C Cordonnier;H Einsele;J Englund

  • T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life.

    J Storek;R P Witherspoon;R Storb

  • Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation.

    Morgan Hakki;Stanley R. Riddell;Jan Storek;Rachel A. Carter

  • Duration of immunosuppressive treatment for chronic graft-versus-host disease.

    Betty L. Stewart;Barry Storer;Jan Storek;H. Joachim Deeg

  • CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantation

    J. Maciej Zaucha;Theodore Gooley;William I. Bensinger;Shelly Heimfeld

  • Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation

    Joseph Pidala;Stephanie J. Lee;Kwang Woo Ahn;Stephen Spellman

  • Reconstitution of the immune system after hematopoietic stem cell transplantation in humans

    Jan Storek;Michelle Geddes;Faisal Khan;Bertrand Huard

  • High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis.

    Richard A. Nash;James D. Bowen;Peter A. McSweeney;Steven Z. Pavletic

  • Immune reconstitution after hematopoietic cell transplantation

    Mark Bosch;Faisal M. Khan;Jan Storek

  • High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes.

    Peter A. McSweeney;Richard A. Nash;Keith M. Sullivan;Jan Storek

  • Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation.

    Jan Storek;Ansamma Joseph;Ansamma Joseph;German Espino;German Espino;Monja A. Dawson;Monja A. Dawson

  • Factors influencing B lymphopoiesis after allogeneic hematopoietic cell transplantation

    Jan Storek;Denise Wells;Monja A. Dawson;Barry Storer

  • Immune reconstitution after anti-thymocyte globulin-conditioned hematopoietic cell transplantation.

    Mark Bosch;Manveer Dhadda;Mette Hoegh-Petersen;Yiping Liu

  • High busulfan exposure is associated with worse outcomes in a daily i.v. busulfan and fludarabine allogeneic transplant regimen.

    Michelle Geddes;S. Bill Kangarloo;Farrukh Naveed;Diana Quinlan

Frequent Co-Authors

James A. Russell
James A. Russell Boston College
David G. Maloney
David G. Maloney Fred Hutchinson Cancer Research Center
Richard A. Nash
Richard A. Nash Fred Hutchinson Cancer Research Center
Rainer Storb
Rainer Storb Fred Hutchinson Cancer Research Center
Keith M. Sullivan
Keith M. Sullivan Duke University
Michael Boeckh
Michael Boeckh Fred Hutchinson Cancer Research Center
Barry E. Storer
Barry E. Storer Fred Hutchinson Cancer Research Center
Bipin N. Savani
Bipin N. Savani Vanderbilt University Medical Center
Ronald E. Gress
Ronald E. Gress National Institutes of Health
Hans Peter Kiem
Hans Peter Kiem Fred Hutchinson Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various healthcare and research career options. For those interested in clinical practice, pursuing a nursing degree can be a complementary path. Many students explore nurse practitioner accelerated program options to advance quickly into specialized patient care roles.

For individuals without a nursing background, 12-month accelerated nursing programs online for non nurses offer an intensive route to gain essential nursing credentials. These programs cater to career changers seeking efficient entry into the nursing field.

Accessibility to nursing education is further supported by easiest accelerated nursing programs, which prioritize streamlined admissions without compromising quality. Similarly, for those aiming to become Licensed Practical Nurses, understanding which lpn programs are easiest to get into can guide applicants toward attainable enrollment opportunities.

These related online degrees not only complement immunology knowledge but also expand career options in healthcare, research, and patient support roles. Choosing the right program depends on individual goals, prior education, and desired specialization within the medical field.

Best Scientists Citing Jan Storek

Trending Scientists

Recently Published Articles